|
ASSAY ITEMS
|
SPECIFICATION
|
|
Appearance
|
White or almost white crystalline powder
|
|
Solubility
|
Soluble in water
|
|
Light Absorption
|
Not more than 0.0015
(440nm, 4cm cell, 50mg/ml)
|
|
Identification
|
A) The IR Spectrum of test sample corresponds to the standard IR spectrum of Lamivudine
|
|
B) The retention time of the major peak in the chromatogram of the test solution corresponds to that in chromatogram of the reference solution, as obtained in the test of Limit of Lamivudine enantiomer.
|
|
|
Water
|
Not more than 0.2%
|
|
Limit of Enantiomer
|
Not more than 0.3%
|
|
Residual
Solvents
|
Ethanol is not more than 0.2%
|
|
Triethylamine (TEA) is not more than 0.1%
|
|
|
Dichloromethane is not more than 0.06%
|
|
|
Toluene is not more than 0.089%
|
|
|
N,N-Dimethylformamide is not more than 0.088%
|
|
|
n-Hexane is not more than 0.029%
|
|
|
Dehydrated alcohol is not more than 0.2%
|
|
|
Isopropyl acetate is not more than 0.2%
|
|
|
Methanol is not more than 0.1%
|
|
|
Triethylamine is not more than 0.1%
|
|
|
Total residual solvents not more than 0.3%
|
|
|
Chromatographic Purity
|
Salicylic acid is not more than 0.10%
|
|
Relative retention time at about 0.4 impurity is not more than 0.3%
|
|
|
Relative retention time at about 0.9 impurity is not more than 0.2%
|
|
|
Any other individual impurity is not more than 0.1%
|
|
|
Total impurities is not more than 0.6%
|
|
|
Assay (dry basis)
|
Not less than 98.0% and not more than 102.0%
|
GMP certified
WHO approved
USP 32 Complied

